puromycin aminonucleoside has been researched along with prednisolone in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, RC; Saito, T | 1 |
Aihara, Y | 1 |
Aoki, M; Tanaka, A; Yatsu, T | 1 |
Colyer, HF; Dasgupta, I; Hurcombe, JA; Jiang, L; Mathieson, PW; Welsh, GI | 1 |
Donaldson, IJ; Fresquet, M; Lennon, R; McCaffrey, JC; Moxey, C; Poolman, TM; Ray, DW; Webb, NJ; Zeef, LAH | 1 |
1 trial(s) available for puromycin aminonucleoside and prednisolone
Article | Year |
---|---|
Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
Topics: Adolescent; Adult; Cells, Cultured; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Levamisole; Male; Middle Aged; Mifepristone; Nephrotic Syndrome; Off-Label Use; Podocytes; Prednisolone; Puromycin Aminonucleoside; Receptors, Glucocorticoid; Signal Transduction; Young Adult | 2015 |
4 other study(ies) available for puromycin aminonucleoside and prednisolone
Article | Year |
---|---|
Contribution of mononuclear leucocytes to the progression of experimental focal glomerular sclerosis.
Topics: Animals; Creatinine; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Leukocytes, Mononuclear; Male; Prednisolone; Protamines; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1990 |
[The effect of drugs to aminonucleoside-induced nephritis].
Topics: Animals; Dipyridamole; Heparin; Kidney Glomerulus; Nephritis; Prednisolone; Puromycin; Puromycin Aminonucleoside; Rats; Rats, Inbred Strains | 1988 |
Effect of zelandopam, a dopamine D1-like receptor agonist, in puromycin aminonucleoside nephrosis rats.
Topics: Animals; Dose-Response Relationship, Drug; Female; Nephrosis; Prednisolone; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Wistar; Receptors, Dopamine D1; Tetrahydroisoquinolines; Time Factors | 2005 |
Glucocorticoid therapy regulates podocyte motility by inhibition of Rac1.
Topics: Antimetabolites, Antineoplastic; Biological Transport; Cell Line, Transformed; Cell Membrane; Cell Movement; Electric Impedance; Gene Expression Profiling; Gene Expression Regulation; Glucocorticoids; Humans; Microarray Analysis; Podocytes; Prednisolone; Protective Agents; Puromycin Aminonucleoside; rac1 GTP-Binding Protein; Receptors, Glucocorticoid; rhoA GTP-Binding Protein; Signal Transduction; Transcriptome | 2017 |